Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 12 03:21PM ET
18.96
Dollar change
+1.40
Percentage change
7.98
%
IndexRUT P/E- EPS (ttm)-2.36 Insider Own15.28% Shs Outstand74.35M Perf Week8.23%
Market Cap1.47B Forward P/E- EPS next Y-2.72 Insider Trans-0.02% Shs Float65.88M Perf Month5.00%
Income-197.55M PEG- EPS next Q-0.66 Inst Own89.84% Short Float16.40% Perf Quarter-0.41%
Sales0.00M P/S- EPS this Y-18.07% Inst Trans-3.05% Short Ratio20.77 Perf Half Y-9.32%
Book/sh5.45 P/B3.48 EPS next Y-10.80% ROA-41.48% Short Interest10.80M Perf Year122.56%
Cash/sh5.85 P/C3.24 EPS next 5Y19.93% ROE-46.28% 52W Range8.17 - 24.17 Perf YTD31.86%
Dividend Est.- P/FCF- EPS past 5Y-3.94% ROI-45.21% 52W High-21.55% Beta0.85
Dividend TTM- Quick Ratio11.47 Sales past 5Y0.00% Gross Margin- 52W Low132.09% ATR (14)0.87
Dividend Ex-Date- Current Ratio11.47 EPS Y/Y TTM-16.69% Oper. Margin0.00% RSI (14)60.31 Volatility5.21% 4.03%
Employees142 Debt/Eq0.04 Sales Y/Y TTM- Profit Margin- Recom1.31 Target Price30.50
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q-25.19% Payout- Rel Volume3.21 Prev Close17.56
Sales Surprise- EPS Surprise-0.62% Sales Q/Q- EarningsNov 07 AMC Avg Volume520.18K Price18.96
SMA207.57% SMA501.50% SMA200-5.96% Trades Volume1,509,790 Change7.98%
Date Action Analyst Rating Change Price Target Change
Oct-24-24Initiated UBS Buy $27
Oct-14-24Downgrade Stifel Buy → Hold $26 → $19
Dec-22-23Initiated Mizuho Buy $26
Aug-11-23Initiated BofA Securities Buy $31
Jul-27-23Initiated Scotiabank Sector Perform $10.50
May-17-23Initiated BTIG Research Buy $31
Jan-31-23Initiated Stifel Buy $25
Jul-12-22Initiated Cantor Fitzgerald Overweight $30
Feb-15-22Initiated Jefferies Buy $35
May-05-21Resumed Credit Suisse Outperform $42
Nov-08-24 04:01PM
Nov-07-24 05:15PM
04:05PM
Nov-05-24 09:09AM
Oct-31-24 07:30AM
08:00AM Loading…
Oct-29-24 08:00AM
Oct-24-24 07:30AM
Oct-23-24 07:30AM
Oct-09-24 05:54PM
Sep-30-24 06:30PM
Sep-17-24 07:30AM
Sep-10-24 07:30AM
Sep-05-24 12:01AM
Sep-02-24 05:22PM
Aug-08-24 04:44PM
04:05PM Loading…
04:05PM
07:30AM
Aug-01-24 07:30AM
Jul-05-24 07:30AM
Jun-24-24 07:30AM
Jun-17-24 09:00AM
Jun-07-24 07:30AM
May-29-24 07:30AM
May-14-24 11:44AM
07:30AM
May-08-24 08:30AM
07:30AM
May-06-24 10:14AM
May-03-24 07:30AM
04:03AM
08:58PM Loading…
May-02-24 08:58PM
04:48PM
04:05PM
Apr-25-24 07:30AM
Apr-22-24 07:30AM
Apr-10-24 07:30AM
Apr-05-24 07:30AM
Mar-06-24 07:30AM
Mar-01-24 05:00PM
Feb-28-24 09:56AM
06:56AM
Feb-27-24 04:44PM
04:10PM
04:01PM
Feb-26-24 07:30AM
Feb-22-24 07:30AM
Feb-20-24 07:30AM
Feb-02-24 07:30AM
Feb-01-24 03:01PM
Jan-30-24 04:07PM
07:00AM
Jan-24-24 04:22PM
01:16PM
07:00AM
Dec-08-23 07:30AM
Nov-28-23 07:30AM
Nov-05-23 03:44PM
Nov-02-23 06:46PM
04:36PM
04:01PM
07:30AM
Oct-30-23 07:30AM
Oct-26-23 04:05PM
Oct-19-23 07:30AM
Oct-17-23 04:05PM
Oct-09-23 02:03AM
Oct-04-23 12:00PM
07:30AM
Sep-28-23 07:30AM
Sep-19-23 07:30AM
Aug-14-23 07:30AM
Aug-03-23 04:38PM
04:05PM
Jul-27-23 07:30AM
Jul-11-23 09:35AM
Jun-14-23 07:00AM
Jun-13-23 04:01PM
Jun-11-23 03:45AM
Jun-05-23 08:02PM
May-30-23 07:30AM
May-23-23 07:30AM
May-13-23 11:51AM
May-11-23 09:35AM
May-10-23 04:17PM
04:03PM
May-09-23 07:30AM
May-03-23 07:30AM
May-01-23 02:07PM
Apr-18-23 07:30AM
Apr-17-23 07:30AM
Mar-14-23 05:32PM
Mar-01-23 07:30AM
Feb-26-23 06:47AM
Feb-24-23 12:52PM
Feb-23-23 04:03PM
Feb-16-23 07:30AM
Feb-12-23 07:14AM
Feb-09-23 07:30AM
Feb-07-23 07:30AM
Jan-31-23 05:43PM
Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bair Teresa BrophyChief Legal OfficerMay 20 '24Sale22.152,61557,91668,979May 20 06:30 PM
DOYLE THOMAS JAMESSVP, Finance & AccountingJan 29 '24Sale17.802,31841,26248,093Jan 31 05:30 PM
Bair Teresa BrophyChief Legal OfficerJan 29 '24Sale17.802,05336,54468,979Jan 31 05:30 PM
FORD KATHLEENChief Operating OfficerJan 29 '24Sale17.801,49626,63021,602Jan 31 05:30 PM
DALE STEPHENChief Medical OfficerJan 29 '24Sale17.807,158127,41643,642Jan 31 05:30 PM
DALE STEPHENChief Medical OfficerJan 30 '24Sale21.554,825103,98038,817Jan 31 05:30 PM
WILSON TROY EDWARDPresident and CEOJan 24 '24Option Exercise6.0591,052550,59484,666Jan 26 05:10 PM
WILSON TROY EDWARDPresident and CEOJan 24 '24Sale20.2391,0521,841,982559Jan 26 05:10 PM